Circulating tumor cells positivity provides an early detection of recurrence of pancreatic cancer

Circulating tumor cells positivity provides an early detection of recurrence of pancreatic cancer

Bibliographic Details
Main Authors:	Hsiu-Tzu Wang, Li-Yuan Bai, Ying-Tso Wang, Hui-Ju Lin, Horng-Ren Yang, Po-Ren Hsueh, Der-Yang Cho
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	Journal of the Formosan Medical Association
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664623000347

Similar Items

Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer
by: Hao Cheng, et al.
Published: (2022-10-01)

Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma
by: Yongrong Lei, et al.
Published: (2021-05-01)

Corrigendum: Association of preoperative NANOG-positive circulating tumor cell levels with recurrence of hepatocellular carcinoma
by: Yongrong Lei, et al.
Published: (2024-07-01)

Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer
by: Jiahong Jiang, et al.
Published: (2020-07-01)

Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer
by: Shuai Ren, et al.
Published: (2023-08-01)

The Potential for Circulating Tumor Cells in Pancreatic Cancer Management
by: Michael Pimienta, et al.
Published: (2017-06-01)

Evaluation of the Rapid Sepsityper protocol and specific MBT-Sepsityper module for the identification of bacteremia and fungemia using Bruker Biotyper MALDI-TOF MS
by: Hsiu-Hsien Lin, et al.
Published: (2022-12-01)

Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
by: Po-Han Lin, et al.
Published: (2021-11-01)

Detection Technology and Prospects of Clinical Application of Circulating Tumor Cells in Pancreatic Cancer
by: YANG Xiaoying, et al.
Published: (2021-09-01)

Characterization of Stem-like Circulating Tumor Cells in Pancreatic Cancer
by: Lei Zhu, et al.
Published: (2020-05-01)

Functional requirement of alternative splicing in epithelial-mesenchymal transition of pancreatic circulating tumor
by: Lixing Xiao, et al.
Published: (2024-03-01)

Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma
by: Han Liu, et al.
Published: (2017-05-01)

Recurrence of Solid Pseudopapillary Tumor: A Rare Pancreatic Tumor
by: Chandra Punch, et al.
Published: (2016-01-01)

Recurrence and Prognostic Value of Circulating Tumor Cells in Resectable Pancreatic Head Cancer: A Single Center Retrospective Study
by: Qiao Zhang, et al.
Published: (2022-04-01)

Pancreatic ductal adenocarcinoma: the role of circulating tumor DNA
by: Joseph R. Habib, MD, et al.
Published: (2019-09-01)

The importance of circulating and disseminated tumor cells in pancreatic cancer
by: Alina Hasanain, et al.
Published: (2019-10-01)

Circulating tumor cells in pancreatic cancer: a review
by: Joseph R. Habib, BS, et al.
Published: (2019-06-01)

Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
by: Jee‐Soo Lee, et al.
Published: (2019-08-01)

Circulating tumor cells in pancreatic cancer: more than liquid biopsy
by: Zeru Li, et al.
Published: (2024-10-01)

Tumor microenvironment participates in metastasis of pancreatic cancer
by: Bo Ren, et al.
Published: (2018-07-01)

Stem cell-like circulating tumor cells identified by Pep@MNP and their clinical significance in pancreatic cancer metastasis
by: Xiangyu Chu, et al.
Published: (2024-06-01)

Circulating tumor cells are a good predictor of tumor recurrence in clinical patients with gastric cancer
by: Wenxing Li, et al.
Published: (2024-06-01)

Applying Intraoperative Insulin Level Monitoring for Tumor Removal in a Patient With Recurrent Pancreatic Multiple Insulinomas
by: Pei-Yin Chen, et al.
Published: (2011-06-01)

Irisin Is a Positive Regulator for Ferroptosis in Pancreatic Cancer
by: Bao Chen Yang, et al.
Published: (2020-09-01)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
by: Shasha Guan, et al.
Published: (2022-08-01)

Prognostic and recurrent significance of SII in patients with pancreatic head cancer undergoing pancreaticoduodenectomy
by: Qing Chen, et al.
Published: (2023-05-01)

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
by: Gui‐Qi Zhu, et al.
Published: (2022-01-01)

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
by: Birte Kulemann, et al.
Published: (2017-07-01)

Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma
by: Kai-Qian Zhou, et al.
Published: (2020-12-01)

Evaluation of Positive and Negative Methods for Isolation of Circulating Tumor Cells by Lateral Magnetophoresis
by: Haeli Kang, et al.
Published: (2019-06-01)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
by: Gong Chen, et al.
Published: (2021-05-01)

The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
by: Alistair Rice, et al.
Published: (2019-09-01)

Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer
by: Shenyi Lian, et al.
Published: (2021-10-01)

Circulating monocytes in acute pancreatitis
by: Shiyu Liu, et al.
Published: (2022-12-01)

Rare causes of recurrent cholangitis after hepaticojejunostomy: A case series
by: Shu-Ying Wang, et al.
Published: (2024-05-01)

Serum levels and positive rates of tumor biomarkers in oral precancer patients
by: Yu-Hsueh Wu, et al.
Published: (2021-06-01)

Circulating CEA‐positive and EpCAM‐negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer
by: Yuichiro Miki, et al.
Published: (2021-01-01)

A recurrence of pancreatic non-functioning neuroendocrine tumor mimicking splenosis
by: Yeon-Ji Kim, et al.

Data of ‘Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage’
by: Patrick Kirchweger, et al.
Published: (2022-04-01)

Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer
by: Young Hoon Choi, et al.
Published: (2022-05-01)